Up next

Autoplay

Olaratumab Plus Doxorubicin in Advanced Soft Tissue Sarcoma

2 Views • 07/18/23
Share
Embed
administrator
administrator
Subscribers
0

William D. Tap, MD, chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses results from a phase Ib/II presented at the 2015 Connective Tissue Oncology Society (CTOS) Annual Meeting.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay